Baxter Total Assets 2006-2019 | BAX

Baxter total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Baxter total assets for the quarter ending March 31, 2019 were $16.350B, a 3.2% decline year-over-year.
  • Baxter total assets for 2018 were $15.641B, a 8.59% decline from 2017.
  • Baxter total assets for 2017 were $17.111B, a 10.07% increase from 2016.
  • Baxter total assets for 2016 were $15.546B, a 25.84% decline from 2015.
Baxter Annual Total Assets
(Millions of US $)
2018 $15,641
2017 $17,111
2016 $15,546
2015 $20,962
2014 $26,138
2013 $25,224
2012 $20,390
2011 $19,073
2010 $17,489
2009 $17,354
2008 $15,405
2007 $15,294
2006 $14,686
2005 $12,727
Baxter Quarterly Total Assets
(Millions of US $)
Q1 2019 $16,350
Q4 2018 $15,641
Q3 2018 $16,847
Q2 2018 $16,578
Q1 2018 $16,890
Q4 2017 $17,111
Q3 2017 $17,541
Q2 2017 $16,963
Q1 2017 $15,659
Q4 2016 $15,546
Q3 2016 $15,795
Q2 2016 $15,982
Q1 2016 $17,350
Q4 2015 $20,962
Q3 2015 $20,172
Q2 2015 $30,015
Q1 2015 $24,861
Q4 2014 $26,138
Q3 2014 $25,563
Q2 2014 $25,629
Q1 2014 $25,261
Q4 2013 $25,224
Q3 2013 $25,250
Q2 2013 $23,751
Q1 2013 $20,318
Q4 2012 $20,390
Q3 2012 $19,825
Q2 2012 $18,446
Q1 2012 $18,784
Q4 2011 $19,073
Q3 2011 $17,843
Q2 2011 $17,741
Q1 2011 $17,413
Q4 2010 $17,489
Q3 2010 $17,563
Q2 2010 $16,487
Q1 2010 $17,166
Q4 2009 $17,354
Q3 2009 $16,954
Q2 2009 $15,743
Q1 2009 $14,953
Q4 2008 $15,405
Q3 2008 $15,209
Q2 2008 $15,470
Q1 2008 $14,972
Q4 2007 $15,294
Q3 2007 $14,147
Q2 2007 $14,659
Q1 2007 $14,483
Q4 2006 $14,686
Q3 2006 $13,931
Q2 2006 $13,007
Q1 2006 $12,780
Q4 2005 $12,727
Q3 2005 $13,783
Q2 2005 $13,626
Q1 2005 $13,808
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $42.165B $11.127B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $151.296B 28.49
Medtronic (MDT) Ireland $135.350B 19.33
Stryker (SYK) United States $77.587B 27.69
Boston Scientific (BSX) United States $58.741B 28.16
EssilorLuxottica Societe Anonyme (ESLOY) France $28.527B 0.00
Coloplast (CLPBY) Denmark $25.661B 40.97
Lonza Group Ag (LZAGY) Switzerland $25.304B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.194B 16.19
Terumo (TRUMY) Japan $22.193B 25.52
Smith & Nephew SNATS (SNN) United Kingdom $19.113B 0.00
ResMed (RMD) United States $17.749B 33.91
Canopy Growth (CGC) Canada $12.652B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Bio-Rad Laboratories (BIO) United States $9.194B 48.74
Aurora Cannabis (ACB) Canada $7.514B 74.10
William Demant Holdings (WILYY) Denmark $7.411B 0.00
Insulet (PODD) United States $7.236B 527.17
Hill-Rom Holdings (HRC) United States $7.121B 21.59
Perrigo (PRGO) Ireland $6.850B 11.58
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.254B 51.05
ICU Medical (ICUI) United States $5.122B 30.57
GW Pharmaceuticals (GWPH) United Kingdom $4.916B 0.00
Neogen (NEOG) United States $3.373B 54.85
NuVasive (NUVA) United States $2.987B 24.39
Hutchison China MediTech (HCM) China $2.906B 0.00
Agios Pharmaceuticals (AGIO) United States $2.848B 0.00
National Vision Holdings (EYE) United States $2.479B 52.82
Quidel (QDEL) United States $2.261B 23.46
Aphria (APHA) $1.646B 0.00
Cardiovascular Systems (CSII) United States $1.530B 878.80
Phibro Animal Health (PAHC) United States $1.212B 18.16
AtriCure (ATRC) United States $1.196B 0.00
VAREX IMAGING (VREX) United States $1.177B 24.98
NanoString Technologies (NSTG) United States $1.065B 0.00
Lantheus Holdings (LNTH) United States $1.052B 27.95
PetIQ (PETQ) United States $1.008B 24.49
Quanterix (QTRX) United States $0.783B 0.00
Cerus (CERS) United States $0.769B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.758B 21.26
Omeros (OMER) United States $0.758B 0.00
MacroGenics (MGNX) United States $0.740B 0.00
TG Therapeutics (TGTX) United States $0.686B 0.00
LeMaitre Vascular (LMAT) United States $0.591B 28.62
Surmodics (SRDX) United States $0.533B 77.45
OraSure Technologies (OSUR) United States $0.522B 24.06
Meridian Bioscience (VIVO) United States $0.489B 14.96
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.398B 0.00
Vapotherm (VAPO) United States $0.337B 0.00
Utah Medical Products (UTMD) United States $0.325B 22.51
BioLife Solutions (BLFS) United States $0.313B 97.88
Zynex (ZYXI) United States $0.242B 24.90
Cytosorbents (CTSO) United States $0.234B 0.00
Bovie Medical (APYX) United States $0.224B 0.00
Chimerix (CMRX) United States $0.184B 0.00
Owens & Minor (OMI) United States $0.178B 3.77
United Health Products (UEEC) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.168B 0.00
Female Health (VERU) United States $0.143B 0.00
Fonar (FONR) United States $0.141B 7.40
Chembio Diagnostics (CEMI) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.97
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.057B 19.58
MRI INTERVENTNS (MRIC) United States $0.053B 0.00